Your browser doesn't support javascript.
loading
The Facility-Level HIV Treatment Cascade: Using a Population Health Tool in Health Care Facilities to End the Epidemic in New York State.
Ikeda, Daniel J; Hollander, Leah; Weigl, Susan; Sawicki, Steven V; Belanger, Daniel R; West, Nova Y; Brey Magnani, Nanette; Wells, Christopher G; Gordon, Peter; Morne, Johanne; Agins, Bruce D.
Afiliación
  • Ikeda DJ; New York State Department of Health AIDS Institute, New York, New York.
  • Hollander L; HEALTHQUAL, Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California.
  • Weigl S; New York State Department of Health AIDS Institute, New York, New York.
  • Sawicki SV; New York State Department of Health AIDS Institute, New York, New York.
  • Belanger DR; New York State Department of Health AIDS Institute, New York, New York.
  • West NY; New York State Department of Health AIDS Institute, New York, New York.
  • Brey Magnani N; New York State Department of Health AIDS Institute, New York, New York.
  • Wells CG; New York State Department of Health AIDS Institute, New York, New York.
  • Gordon P; New York State Department of Health AIDS Institute, New York, New York.
  • Morne J; Division of Infectious Diseases, Department of Medicine, Columbia University, New York, New York.
  • Agins BD; New York State Department of Health AIDS Institute, New York, New York.
Open Forum Infect Dis ; 5(10): ofy254, 2018 Oct.
Article en En | MEDLINE | ID: mdl-30386808
BACKGROUND: The HIV treatment cascade is a tool for characterizing population-level gaps in HIV care, yet most adaptations of the cascade rely on surveillance data that are ill-suited to drive quality improvement (QI) activities at the facility level. We describe the adaptation of the cascade in health care organizations and report its use by HIV medical providers in New York State (NYS). METHODS: As part of data submissions to the NYS Department of Health, sites that provide HIV medical care in NYS developed cascades using facility-generated data. Required elements included data addressing identification of people living with HIV (PLWH) receiving any service at the facility, linkage to HIV medical care, prescription of antiretroviral therapy (ART), and viral suppression (VS). Sites also submitted a methodology report summarizing how cascade data were collected and an improvement plan identifying care gaps. RESULTS: Two hundred twenty-two sites submitted cascades documenting the quality of care delivered to HIV patients presenting for HIV- or non-HIV-related services during 2016. Of 101 341 PLWH presenting for any medical care, 75 106 were reported as active in HIV programs, whereas 21 509 had no known care status. Sites reported mean ART prescription and VS rates of 94% and 80%, respectively, and 60 distinct QI interventions. CONCLUSIONS: Submission of facility-level cascades provides data on care utilization among PLWH that cannot be assessed through traditional HIV surveillance efforts. Moreover, the facility-level cascade represents an effective tool for identifying care gaps, focusing data-driven improvement efforts, and engaging frontline health care providers to achieve epidemic control.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos